NCT01094886: Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee Replacement |
|
|
| Completed | 3 | 56 | US | Rivaroxaban | Ortho-McNeil Janssen Scientific Affairs, LLC, Bayer | Arthritis, Osteoarthritis, Knee, Osteoarthritis, Hip, Thromboembolism | 12/10 | 12/10 | | |
